Surrozen (SRZN)
Develops multifunctional Wnt-mimetic biologics for serious retinal vascular and inflammatory eye diseases.
$23.79
Pre-market+1.22 (+5.41%)
At close$22.57(+1.67%)
Something off on this page? Send us feedback.
Next report
Nov 6, 2026
in 64 days
EPS estimate
−$1.10
Revenue estimate
$467.3K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$9.10−$3.13−$1.14−$3.61−$7.59−$4.63−$0.41Pending
Estimate−$2.54−$1.09−$1.23−$1.17−$1.41−$1.39−$1.29−$1.10
Surprise−258.3%−187.2%+7.3%−208.5%−438.3%−233.1%+68.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$655.0K$983.0K$983.0K$983.0K$514.0K$5.0M$5.0MPending
Estimate————$661.0K$4.0M$467.3K$467.3K
Surprise————−22.2%+25.0%+970.1%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.10 | — | — |
| Aug 2026 | −$1.29 | −$0.41 | +68.2% |
| May 2026 | −$1.39 | −$4.63 | −233.1% |
| Mar 2026 | −$1.41 | −$7.59 | −438.3% |
| Nov 2025 | −$1.17 | −$3.61 | −208.5% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | −$1.10 | — | — | $467.3K | — | — | — |
| Aug 6, 2026 | −$1.29 | −$0.41 | +68.2% | $467.3K | $5.0M | +970.1% | +18.4% |
| May 6, 2026 | −$1.39 | −$4.63 | −233.1% | $4.0M | $5.0M | +25.0% | −9.9% |
| Mar 23, 2026 | −$1.41 | −$7.59 | −438.3% | $661.0K | $514.0K | −22.2% | −1.0% |
| Nov 7, 2025 | −$1.17 | −$3.61 | −208.5% | — | $983.0K | — | −3.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||||||
| Aug 8, 2025 | |||||||
| May 9, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 6, 2021 | |||||||
| Jul 15, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Jan 4, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||